Kyowa Kirin Co (TSE:4151) 3-Year EBITDA Growth Rate : 10.50% (As of Sep. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co 3-Year EBITDA Growth Rate?

Kyowa Kirin Co's EBITDA per Share for the three months ended in Sep. 2023 was 円81.79.

During the past 12 months, Kyowa Kirin Co's average EBITDA Per Share Growth Rate was -5.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 10.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 1.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 0.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kyowa Kirin Co was 16.20% per year. The lowest was -14.00% per year. And the median was 3.20% per year.

Competitive Comparison of Kyowa Kirin Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyowa Kirin Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's 3-Year EBITDA Growth Rate falls into.

Kyowa Kirin Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Kyowa Kirin Co (TSE:4151) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Kyowa Kirin Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyowa Kirin Co (TSE:4151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

KYKOY:USA KYKOF:USA

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines